Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

GALT

GALT News

Newswire

17:13

Galectin Therapeutics 10% Owner Sells 30000 Shares at $5.47 and 120000 Shares at $5.73

15:03

Galectin shares surge 12.28% intraday after positive Belapectin trial data and strong Q3 2025 financials.

12:04

Galectin Therapeutics Reports Record High Stock Prices, CEO Expresses Excitement

12:10

Galectin's 15min chart triggered MACD Death Cross, KDJ Death Cross alert.

02:46

Galectin Therapeutics' NAVIGATE Data Validates Fibrosis Thesis

View More

About GALT

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More